Home/Hedge Fund Intelligence/CRISPR Therapeutics AG
Nasdaq: CRSPStockForm 13F30 Jun 2026

Hedge funds that hold CRISPR Therapeutics AG Namen Akt Nasdaq: CRSP

Namen Akt · CUSIP H17182108 · who reports it, how much, and how much it matters to them

23 of the 720 hedge fund managers we track reported shares of CRISPR Therapeutics AG (Nasdaq: CRSP) on Form 13F for 30 June 2026. Between them they reported USD 333m. The largest position belongs to Two Sigma Investments, at USD 108m. The manager with the most riding on it is ECOR1 Capital, where it is 3.7% of the reported book.

Managers reporting it23of 720 we track
Value they reportUSD 333mshares only, 30 Jun 2026
Funds they run218with a file on PPLI.com
Largest positionUSD 108mTwo Sigma Investments
Typical weight0.0%median share of a manager's book
Heaviest weight3.7%ECOR1 Capital

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

23 managers, USD 333m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports CRISPR Therapeutics AG, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Two Sigma Investments35 funds on PPLI.comUSD 108m0.1%
2ECOR1 Capital3 funds on PPLI.comUSD 76m3.7%
3D. E. Shaw & Co.15 funds on PPLI.comUSD 49m0.0%
4Citadel Advisors32 funds on PPLI.comUSD 25m0.0%
5Millennium Management6 funds on PPLI.comUSD 21m0.0%
6Logos Global Management1 fund on PPLI.comUSD 16m0.7%
7Squarepoint Ops7 funds on PPLI.comUSD 16m0.0%
8Campbell & Company Investment Adviser8 funds on PPLI.comUSD 5.9m0.3%
9Capital Fund Management S.A.12 funds on PPLI.comUSD 4.9m0.0%
10Tudor Investment Corporation10 funds on PPLI.comUSD 2.3m0.0%
11Palo Alto Investors6 funds on PPLI.comUSD 2.2m0.3%
12Exoduspoint Capital Management7 funds on PPLI.comUSD 1.6m0.0%
13Dark Forest Capital Management2 funds on PPLI.comUSD 1.4m0.1%
14Walleye Capital8 funds on PPLI.comUSD 1.3m0.0%
15Brevan Howard Capital Management39 funds on PPLI.comUSD 680,0000.0%
16Engineers Gate Manager1 fund on PPLI.comUSD 585,0000.0%
17Diametric Capital2 funds on PPLI.comUSD 349,0000.0%
18Fora Capital1 fund on PPLI.comUSD 309,0000.0%
19Prelude Capital Management9 funds on PPLI.comUSD 299,0000.0%
20LMR Partners2 funds on PPLI.comUSD 273,0000.0%
21Freestone Grove Partners1 fund on PPLI.comUSD 45,1050.0%
22Persistent Asset Partners10 funds on PPLI.comUSD 11,8900.0%
23The Quarry1 fund on PPLI.comUSD 1640.0%
Next: where it matters most
Where it matters most

For ECOR1 Capital it is 3.7% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1ECOR1 CapitalUSD 76m3.7%
2Logos Global ManagementUSD 16m0.7%
3Campbell & Company Investment AdviserUSD 5.9m0.3%
4Palo Alto InvestorsUSD 2.2m0.3%
5Dark Forest Capital ManagementUSD 1.4m0.1%
6Two Sigma InvestmentsUSD 108m0.1%
7Diametric CapitalUSD 349,0000.0%
8D. E. Shaw & Co.USD 49m0.0%
9Prelude Capital ManagementUSD 299,0000.0%
10Capital Fund Management S.A.USD 4.9m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds CRISPR Therapeutics AG

What is the ticker symbol of CRISPR Therapeutics AG?

CRISPR Therapeutics AG trades under the symbol CRSP on the Nasdaq. Its CUSIP, the code used on Form 13F, is H17182108.

Which hedge funds own CRISPR Therapeutics AG (Nasdaq: CRSP)?

23 of the 720 hedge fund managers PPLI.com tracks reported CRISPR Therapeutics AG shares on Form 13F for 30 June 2026. The largest reported positions were held by Two Sigma Investments (USD 108m), ECOR1 Capital (USD 76m), D. E. Shaw & Co. (USD 49m), Citadel Advisors (USD 25m) and Millennium Management (USD 21m).

How many hedge funds hold CRISPR Therapeutics AG?

23 managers in our coverage reported it, and between them they run 218 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on CRISPR Therapeutics AG?

ECOR1 Capital, where the position was 3.7% of the reported 13F book at 30 June 2026.

Does this show who is short CRISPR Therapeutics AG?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with CRISPR Therapeutics AG or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.